In addition, Fang et al. [15] found that XIST could mediate its oncogenic effects through epigenetically silencing the expression of Kruppel-like factor (KLF2) via directly binding with enhancer of zeste homolog 2 (EZH2) in non-small-cell lung cancer. This evidence concerns the gene KLF2 and non-small cell lung carcinoma.